New insider activity at biote ( (BTMD) ) has taken place on April 8, 2025.
Significant shareholder Guines LLC has made a notable acquisition by purchasing 74,440 shares of Biote stock, amounting to a total investment of $237,281.
Recent Updates on BTMD stock
Biote (BTMD) has seen significant developments recently, with several board members and CEO Bret Christensen purchasing approximately 260,000 shares, signaling confidence in the company’s strategy and long-term outlook. Despite this, analysts have adjusted their price targets for Biote, with TD Cowen lowering it to $6 from $8, citing the need for improved execution to reduce business volatility, even as the market opportunity remains attractive. Craig-Hallum also reduced their target to $8 from $12 due to slightly lower-than-expected Q4 results and guidance for 2025, attributed to disruptions from new decision support software. Biote’s recent earnings call highlighted revenue growth and improved profit margins but also noted challenges such as declining net income and increased expenses, leading to a mixed sentiment. The company is focusing on strategic investments and expanding its practitioner network to drive future growth.
Spark’s Take on BTMD Stock
According to Spark, TipRanks’ AI Analyst, BTMD is a Neutral.
The company’s overall stock score reflects solid revenue growth and efficient cash flow management, offset by high leverage and negative equity. Technical indicators suggest bearish momentum, while the valuation is moderate with a fair P/E ratio. The earnings call provided positive guidance for 2025, though challenges such as increased expenses and slowed customer growth remain. Strategic initiatives may improve financial stability and market position if successfully implemented.
To see Spark’s full report on BTMD stock, click here.
More about biote
YTD Price Performance: -45.44%
Average Trading Volume: 203,401
Technical Sentiment Signal: Strong Buy
Current Market Cap: $180M